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Abstract
Myoid hamartomas of the breast are extremely rare breast lesions, with a poorly understood pathogenesis. We
describe the case of a 38-year-old premenopausal woman who presenting with a mass in the left breast.
Mammography revealed an oval mass that was partly indistinct, and ultrasonography showed a hypoechoic mass
with a slightly irregular margin. Bilateral breast dynamic magnetic resonance imaging was performed for a more
detailed evaluation. The images showed rapid initial enhancement and a microlobulated margin. Because the
suspicion of malignancy was strong at that time, core needle biopsy was performed. Histologically, the tumor was
identified as fibroadenoma. A case of myoid hamartoma of the breast that proved difficult to diagnose is reported,
and discussed with reference to the literature.
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Background
Hamartoma is an uncommon breast tumor that histolo-
gically contains lobular breast tissue with various admix-
tures of fibrous, fibrocystic, and adipose tissue [1,2].
Myoid hamartoma is an extremely rare subtype contain-
ing an additional smooth muscle component [3]. Both
radiographic correlations and immunohistochemical stu-
dies are important to diagnose myoid hamartoma and
avoid confusion with other breast diseases. Herein, we
report a case of myoid hamartoma of the breast that
proved difficult to diagnoses because the findings on
morphological evaluation employing various imaging
modalities were different from the histological findings
of core needle biopsy.
Case presentation
A 38-year-old, premenopausal woman was admitted
with a mass of the left breast. Family and past medical
histories were unremarkable. Physical examination
revealed a 19 × 28-mm mass in the upper outer quad-
rant of the left breast. The tumor was mobile and not
fixed to the chest wall. The lymph nodes were not
palpable in the left axilla, and no mass was present in
the right breast. The patient was referred for mammo-
graphy and ultrasonography. Mammography showed a
22-mm, well-demarcated, oval, isodense mass that was
partly indistinct (BI-RADS category 4) (Figure 1), and
ultrasonography revealed a 20 × 15 × 8.8-mm, well-
demarcated, hypoechoic lesion with slightly irregular
margins in the outer part of the left breast (Figure 2).
Because the possibility of malignancy could not be ruled
out from these findings, bilateral breast dynamic mag-
netic resonance imaging (MRI) was performed. MRI dis-
played a well-circumscribed mass with high signal
intensity on T2-weighted images (T2WI) (Figure 3a).
On contrast-enhanced T1-weighted images (T1WI), the
mass showed strong enhancement with a microlobulated
margin (Figure 3b). Dynamic contrast-enhanced imaging
demonstrated rapid enhancement of the mass. The sig-
nal intensity peaked within 90 seconds after the intrave-
nous injection of the contrast medium gadolinium
( F i g u r e3 c - f ) .B e c a u s et h ep o s s i b i l i t yo fm a l i g n a n c y
could also not be ruled out from these findings, core
needle biopsy was performed. Histologically, the tumor
was identified as fibroadenoma with focal mastopathic
change. A lumpectomy was carried out under general
anesthesia with a 10-mm margin to the adjacent breast
tissue on the request of the patient 2 months later.
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the cut surface of the lesion showed a yellow-white,
well-circumscribed, non-encapsulated mass, resembling
a fibroadenoma (Figure 4).
Microscopically, Hematoxylin and eosin staining
showed benign ductal and lobular units, adipose tissue,
fibrous stroma and bundles of elongated spindle cells in
a disorganized pattern (Figure 5a). Immunohistochemi-
cally, the smooth muscle tissue stained diffusely positive
for smooth-muscle actin (SMA), vimentin, desmin, and
HHF35 (Figure 5b-d). In contrast, both cytokeratin and
S-100 protein expressions in the stroma were negative.
Discussion
Breast hamartomas comprise about 0.7-5% of all benign
breast masses, and their main characteristic is the variety
of tissue they contain [4]. Myoid hamartoma is a rare
benign lesion of the breast, and is considered a variant of
mammary hamartoma [5]. It was described for the first
time in 1973 by Davies and Riddell [6]. According to
some reports, this lesion is well-circumscribed and shows
oval or round opacity on mammography, and ultrasono-
graphy reveals an internally iso- or hypoechoic, solid
mass with regular margins [7,8]. Concerning mammogra-
phy and ultrasonography, the findings of the present case
are different from previous reports of myoid hamartoma.
On the other hand, few reports have described dynamic
MRI findings for myoid hamartoma. Wong et al. reported
that the signal intensity curve shows an early and signifi-
cant rise on dynamic contrast enhancement [8]. Ko et al.
revealed early intense enhancement and washout on
dynamic MRI [9]. In the present case, the mass showed
strong enhancement with a microlobulated margin on
T1WI, and rapid enhancement on dynamic MRI, which
differed from ordinary hamartoma [10].
Figure 1 Mammography of the left breast, showing a 1.1 ×
2.2-cm, well-demarcated, oval, isodense mass that was partly
indistinct (arrow).
Figure 2 Ultrasonography of the breast shows a 20 × 15 × 8.8-
mm, well-demarcated, low-echoic lesion with slightly irregular
margins (arrow).
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myoid hamartoma might be wrong if only a few bioptic
tissues could be taken, such as in core needle biopsy.
They recommend open excisional biopsy to reach a
more decisive diagnosis [3,11,12].
The histological differential diagnosis of myoid hamar-
toma should include various benign and malignant spin-
dle cell tumors and tumor-like lesions. Lesions that
should be considered include fibroadenoma, adeno-
myoepithelioma, leiomyosarcoma, and metaplastic breast
carcinoma [13-15].
Immunohistochemical studies were helpful in making
a diagnosis, and several reports have suggested that
spindle and epithelioid tumor cells show strong positive
staining for SMA, desmin, and vimentin, and the
absence of staining for cytokeratin as well as S-100 pro-
tein [3,5,15,16]. In the present case, the stroma stained
strongly for SMA, desmin, and HHF35, consistent with
previous reports.
In this case, we followed the diagnosis according to
core needle biopsy, which is very useful to differenti-
ate between benign and malignant lesions. However,
diagnosing a rare disease such as myoid hamartoma
using the limited tissue yield of core needle biopsy is
difficult [3,11,17]. In addition, the findings on mam-
mography, ultrasonography, and dynamic MRI were
different from the histological findings of core needle
biopsy.
Conclusion
In the diagnosis of myoid hamartoma, open excisional
biopsy and immunohistochemical studies are crucial,
and help to avoid confusion with various benign and
malignant spindle cell tumors.
Figure 4 Gross pathologic appearance of the myoid
hamartoma. The cut surface of the lesion shows a yellow-white,
well-circumscribed, non-encapsulated mass, resembling a
fibroadenoma.
Figure 5 Hematoxylin and eosin and immunohistochemical
staining of the breast tumor specimen. a) Hematoxylin and eosin
staining of the breast tumor specimen shows a delicately
encapsulated mass comprising fibrous and adipose tissue (Original
magnification × 50). b-d) Immunohistochemical staining for smooth
muscle actin, desmin, and HHF35 shows the smooth muscle
histogenesis of stromal spindle cells (Original magnification × 150).
Figure 3 a) MRI of the left breast, showing a well-
circumscribed mass with a high signal intensity on T2WI.b )O n
contrast-enhanced T1WI, the left breast lesion appeared as an
enhanced mass with a microlobulated margin. c-f) The lesion on
dynamic contrast MRI shows a peak in signal intensity within 90
seconds, after contrast injection.
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Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this medical journal.
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